Publikace
- In silico library screening to find novel anticancer agent with chemosensitizing properties: focus on targeting ataxia telangiectasia and Rad3 related kinase2024 | Lékařská fakulta v Hradci Králové
- Novel quinazolin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity2019 | Lékařská fakulta v Hradci Králové
- Novel caffeine derivatives with antiproliferative activity2016 | Lékařská fakulta v Hradci Králové
- Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy2016 | Publikace bez příslušnosti k fakultě
- 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment2015 | Publikace bez příslušnosti k fakultě
- 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies2014 | Přírodovědecká fakulta, Farmaceutická fakulta v Hradci Králové
- 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE12023 | Farmaceutická fakulta v Hradci Králové
- 7-Azaindole, 2,7-diazaindole, and 1H-pyrazole as core structures for novel anticancer agents with potential chemosensitizing properties2022 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Clinical Candidates Targeting the ATR-CHK1-WEE1 Axis in Cancer2021 | Publikace bez příslušnosti k fakultě
- Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy2020 | Lékařská fakulta v Hradci Králové
Loading network view...
